Opportunity overview
To provide a comprehensive, integrated portfolio of drug-development products and services, preclinical research and toxicology studies to support ongoing research for anticancer compound CADD522.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Charles River Laboratories
Match pending…
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 1 Apr 2025
- Award ID
- 1
- Status
- active
- Location
- Tranent, UKM73, EH33 2NE, United Kingdom
Classification
No classification was supplied.
Lots
- Lot 1Value not stated
Documents and notices
- Contract details notice on Find a TenderOpen source ↗